Leukemia
- Leukemia, not otherwise specified, Leukemia, other, Myeloid and Monocytic LeukemiaA Randomized, Double-blind, Placebo-controlled Phase III Multi-center Study of Azacitidine With or Without MBG453 for the Treatment of Patients With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)Principal Investigator: Amer Zeidan
- Leukemia, not otherwise specified, Leukemia, other, Myeloid and Monocytic LeukemiaA Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Azacitidine in Patients Newly Diagnosed With Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)Principal Investigator: Amer Zeidan
- Myeloid and Monocytic LeukemiaA Phase 1, Parallel, Open-Label Study of the Safety and Tolerability, Pharmacokinetics, and Antileukemic Activity of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)Principal Investigator: Amer Zeidan
- Leukemia, not otherwise specified, Leukemia, other, PediatricsA Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Thromboembolism Prevention Versus No Systemic Anticoagulant Prophylaxis During Induction Chemotherapy in Children With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoma (T or B Cell) Treated With AsparaginasePrincipal Investigator: Nina Kadan-Lottick
- Leukemia, otherPhase 1B Study of PTC299 in Relapsed/Refractory Acute LeukemiasPrincipal Investigator: Thomas Prebet